Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Brock

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Medical Oncology (Northwood, London, England)|June 1, 1997
Current perspectives in gliomasC S Brock, M Bower
The European Respiratory Journal|April 9, 2002
Anti-angiogenic strategies and vascular targeting in the treatment of lung cancerC S Brock, S M Lee
European Journal of Nuclear Medicine|June 1, 1997
Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?C S Brock, S R Meikle, P Price
Journal of HIV Therapy|October 27, 2007
A case series of HIV-positive patients with malignant melanomaR M Webster, N Sarwar, H Price, et al.
International Journal of Oncology|April 6, 2005
Glucose metabolism in brain tumours can be estimated using [18F]2-fluorodeoxyglucose positron emission tomography and a population-derived input function scaled using a single arterialised venous blood sampleC S Brock, H Young, S Osman, et al.
BJU International|March 17, 2001
Trends in testicular carcinoma in England and Wales, 1971-99D A Power, R S Brown, C S Brock, et al.
Neuroradiology|September 26, 2003
MRI of the brain with ultra-short echo-time pulse sequencesA Waldman, J H Rees, C S Brock, et al.
Journal of HIV Therapy|October 27, 2007
An HIV-associated mediastinal germ cell tumour complicated by acute myeloid leukaemiaA M Young, T Powles, P Holmes, et al.
British Journal of Cancer|February 22, 2000
Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomasC S Brock, H Young, S M O'Reilly, et al.
Cancer Chemotherapy and Pharmacology|July 31, 1998
Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: a feasibility studyS R Meikle, J C Matthews, C S Brock, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Medical Oncology (Northwood, London, England)|June 1, 1997
Current perspectives in gliomasC S Brock, M Bower
The European Respiratory Journal|April 9, 2002
Anti-angiogenic strategies and vascular targeting in the treatment of lung cancerC S Brock, S M Lee
European Journal of Nuclear Medicine|June 1, 1997
Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?C S Brock, S R Meikle, P Price
Journal of HIV Therapy|October 27, 2007
A case series of HIV-positive patients with malignant melanomaR M Webster, N Sarwar, H Price, et al.
International Journal of Oncology|April 6, 2005
Glucose metabolism in brain tumours can be estimated using [18F]2-fluorodeoxyglucose positron emission tomography and a population-derived input function scaled using a single arterialised venous blood sampleC S Brock, H Young, S Osman, et al.
BJU International|March 17, 2001
Trends in testicular carcinoma in England and Wales, 1971-99D A Power, R S Brown, C S Brock, et al.
Neuroradiology|September 26, 2003
MRI of the brain with ultra-short echo-time pulse sequencesA Waldman, J H Rees, C S Brock, et al.
Journal of HIV Therapy|October 27, 2007
An HIV-associated mediastinal germ cell tumour complicated by acute myeloid leukaemiaA M Young, T Powles, P Holmes, et al.
British Journal of Cancer|February 22, 2000
Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomasC S Brock, H Young, S M O'Reilly, et al.
Cancer Chemotherapy and Pharmacology|July 31, 1998
Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: a feasibility studyS R Meikle, J C Matthews, C S Brock, et al.
Pageof 2